Aeson Therapeutics' Other Investors

Aeson Therapeutics raised a round of funding on , . Investors include Research Corporation Technologies.

Dehydroepiandrosterone (DHEA) may have therapeutic uses against cardiovascular disease, immune disorders, cancer and other diseases, but the hormone is a precursor of androgens and estrogens and can c…

Articles about Aeson Therapeutics' Other Investors: